Teresa A. Colvin, Ph.D. - Publications
Affiliations: | 2014 | Molecular Medicine GMS | Boston University, Boston, MA, United States |
Area:
Biochemistry, Medicine and Surgery, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2016 | Gabai VL, Yaglom J, Wang Y, Meng L, Shao H, Kim G, Colvin T, Gestwicki J, Sherman MY. Anti-cancer effects of targeting Hsp70 in tumor stromal cells. Cancer Research. PMID 27503927 DOI: 10.1158/0008-5472.Can-16-0800 | 0.431 | |||
2015 | Li X, Colvin T, Rauch JN, Acosta-Alvear D, Kampmann M, Dunyak B, Hann B, Aftab BT, Murnane M, Cho M, Walter P, Weissman JS, Sherman MY, Gestwicki JE. Validation of the hsp70-bag3 protein-protein interaction as a potential therapeutic target in cancer. Molecular Cancer Therapeutics. 14: 642-8. PMID 25564440 DOI: 10.1158/1535-7163.Mct-14-0650 | 0.478 | |||
2014 | Colvin TA, Gabai VL, Gong J, Calderwood SK, Li H, Gummuluru S, Matchuk ON, Smirnova SG, Orlova NV, Zamulaeva IA, Garcia-Marcos M, Li X, Young ZT, Rauch JN, Gestwicki JE, et al. Hsp70-Bag3 interactions regulate cancer-related signaling networks. Cancer Research. 74: 4731-40. PMID 24994713 DOI: 10.1158/0008-5472.Can-14-0747 | 0.451 | |||
2014 | Colvin TA, Gabai VL, Sherman MY. Proteotoxicity is not the reason for the dependence of cancer cells on the major chaperone Hsp70. Cell Cycle (Georgetown, Tex.). 13: 2306-10. PMID 24911412 DOI: 10.4161/Cc.29296 | 0.463 | |||
Show low-probability matches. |